Life Technologies, a Nasdaq-listed medical technologies provider, has acquired corporate venturing-backed BAC, a Netherlands-based company purifying proteins for testing, for an undisclosed amount.
Spun out from Anglo-Dutch consumer goods conglomerate Unilever in 1995, BAC said its shareholders included Unilever Ventures and family office FF&P Private Equity.
Its investors provided money in 2005 and a €1.5m series B round in September 2008.